How Patient Access, Mistrust Burden Biosimilars
Source: Bioprocess Online
Celltrion VP of Medical Affairs Hetal Patel, PharmD, MBA addresses challenges such as access, affordability, and trust in biosimilars in this segment of our Bioprocess Online Live panel discussion Impact Of The Biosimilars Boom. She emphasizes the need for transparent communication, provider-patient alignment, and overcoming misinformation and hesitation.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more